Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-27
1997-06-17
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 62, 546 61, 546 70, 546 64, 540577, 540578, 514215, 514284, 514287, 544184, 544216, 544233, 544247, 544343, C07D491048, C07D21502, C07D491052, A61K 3144
Patent
active
056397593
ABSTRACT:
This invention relates to carbocyclic and heterocyclic fused-ring quinolinecarboxylic acid compounds, to pharmaceutical compositions comprising such compounds, and to methods of using such compounds for the treatment and/or prevention of organ transplantation rejection, graft versus host disease, autoimmune diseases, chronic inflammatory diseases, including but not limited to psoriasis and rheumatoid arthritis, and cancer in a mammal.
REFERENCES:
patent: 4680299 (1987-07-01), Hesson
patent: 4847381 (1989-07-01), Sutherland et al.
patent: 4918077 (1990-04-01), Behrens
patent: 4968701 (1990-11-01), Ackerman et al.
patent: 4968702 (1990-11-01), Poletto et al.
patent: 5135934 (1992-08-01), Behrens
patent: 5225418 (1993-07-01), Miller
Jadwign Schoen and Krystynn Bogdanowicz-Szwed., Chemical Abstracts 61:1827g.
E. Noelting and A. Herzbaum., Chem. Ber. vol. 44, 2585, 1991.
N. P. Buu-Hoi, V. Bellavita, A. Ricci, J. P. Hoeffinger and D. Balucani., J. Chem. Soc. (C), 47, 1966.
Kamane Takagi et Takeo Ueda., Chem. Pharm. Bull, vol. 19, 1218, 1971.
Kamane Takagi et Takeo Ueda., Chem. Pharm. Bull, vol. 20, 2051, 1972.
Ng. Ph. Buu-Hoi., J. C. S., 2418, 1958.
par Paul Cagniant, Alfred Reisse (**) et Denise Cagniant., Bulletin Se La Societe Chimique De France, 991, (1969). [Bull. Soc. Chem. France, 991, (1969)].
par Paul Cagniant, Guy Merle (**) et Denise Cagniant., Bulletin Se La Societe Chimique De France, 322, (1970). [Bull. Soc. Chem. France, 322, (1970)].
Von Rolf Huisgen, Ivar Ugi., Liebigs Ann. Chem. Bd., 610, 57, (1957).
Kinoshita Yukihiko, Ajisawa Yukiyoshi, Ikeguchi Seiichi, Ujiie Shinsei and Tsutsimi Naoyuki., 1-Pharmacology, vol. 111:187618h, (1989).
Seiji Yamaguchi, Kunihiro Tsuzuki, Yoshie Sannomiya, Yutaka Oh-hira and Yoshiyuki Kawase., J. Heterocyclic Chem., 26, 285, (1989).
Degutis J, Ezerskaite A., Chemical Abstracts vol. 107:39658y, (1987).
Ezerskaite A, Degutis J, Undzenas A, Kalcheva V., Chemical Abstracts vol.112: 66492z, (1990).
Ezerkaite A, Kalcheva V, Peshakova L., 28-Heterocycles vol.113:58979u, (1990).
Fravolini Arnaldo, Rodriguez Salazar Carlos., Chemical Abstracts vol.70:47334x, (1969).
Fravolini Arnaldo, Rodriguez Salazar Carlos., Ann. Chim. (Rome) vol.58, 1155-62, (1968).
Wang Jinjun, Yin Bingzhu, Jiang Guiji., Chemical Abstracts vol.115:49457m, (1991).
Wang Jinjun, Jiang Guiji, Fang Wenlong, Jin Jingji., Chemical Abstracts vol.115:183138m, (1991).
Odette Roussel, N.P. Buu-Hoi and P. Jacquignon., J. Chem. Soc., 5458, (1965).
Antonio Da Settimo, Giampaolo Primofiore, Orsete Livi, Pier Luigi Ferrarini and Silvano Spinelli., J. Heterocyclic Chemistry, vol. 16, 169-174, (1979).
John T. Brauholtz and Fredrick G. Mann., J. Chem. Soc., 3377, (1958).
George R. Procter and Brian M.L.Smith., J.C.S. Perkin I, 862-870, (1978).
S. J. Holt and V. Petrow., J.C.S., 607-611, (1947).
John T. Brauholtz and Frederick G. Mann., J. C. S., 381-392, (1955).
Frederick G. Mann., J.C.S., 2816-2824, (1949).
Julius V. Brown and Karl Weissbach., Chem. Ber. vol. 62, 2416-2425, (1929).
A. K. Kiang and Frederick G. Mann., J.C.S. 1909-1914, (1951).
N.P. Buu-Hoi and G Saint-Ruf., 38-Heterocyclic Compounds 11998, (1964).
D. Huckle, I. M. Lockhart and N.E. Webb., J. Chem. Soc. (C), 2252-2260, (1971).
Hoi Jirul. Wang Jinjun, Jiang Guiji, Li Jingahu., 29-Heterocycles vol.116:128709u, (1992).
Batt Douglas Guy
Behrens Carl Henry
Jacobson Irina Cipora
Magolda Ronald Louis
Orwat Michael James
Ferguson Blair Q.
Shah Mukund J.
The DuPont Merck Pharmaceutical Company
Wong King Lit
LandOfFree
Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157978